Skip to main content
Download PDF

Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma

BMC Cancer volume 16, Article number: 272 (2016) Cite this article

The Original Article was published on 25 February 2016

Erratum

Following publication of this work [1] the authors noticed a mistake within the article’s competing interests section. The correct competing interests section is provided below.

Reference

  1. Okuma Y, Hosomi Y, Miyamoto S, Shibuya M, Okamura T, Hishima T. Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. BMC Cancer. 2016;16:156. doi:10.1186/s12885-016-2159-7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo, Tokyo, 113-8677, Japan

    Yusuke Okuma, Yukio Hosomi, Masahiko Shibuya & Tatsuru Okamura

  2. Division of Oncology, Research Center for Medical Sciences, The Jikei University School of Medicine, Minato, Tokyo, Japan

    Yusuke Okuma

  3. Department of Clinical Oncology, Japan Red Cross Medical Center, Shibuya, Tokyo, Japan

    Shingo Miyamoto

  4. Department of Pathology, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Bunkyo, Tokyo, Japan

    Tsunekazu Hishima

Authors
  1. Yusuke Okuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yukio Hosomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shingo Miyamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masahiko Shibuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tatsuru Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tsunekazu Hishima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yusuke Okuma.

Additional information

Competing interests

The authors declare that they have no competing interests. This study is supported by the grant for the Clinical Research of Tokyo Metropolitan Hospital and Taiho Pharmaceutical Inc. who analyzed the thymidine synthase, thymidine phosphorylase, orotate phosphoribosyltransferase, and dihydropyrimidine dehydrogenase using RT-PCR.

The online version of the original article can be found under doi:10.1186/s12885-016-2159-7.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okuma, Y., Hosomi, Y., Miyamoto, S. et al. Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. BMC Cancer 16, 272 (2016). https://doi.org/10.1186/s12885-016-2309-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-016-2309-y

BMC Cancer

ISSN: 1471-2407

Contact us